{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:08:33Z","timestamp":1780416513907,"version":"3.54.1"},"posted":{"date-parts":[[2026,4,17]]},"group-title":"In Review","reference-count":0,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,4,8]]},"abstract":"<title>Abstract<\/title>\n                <p>Glioblastoma (GBM) is characterized by aberrant neovascularization and angiogenesis. Bevacizumab (Avastin), a monoclonal antibody targeting vascular endothelial growth factor (VEGF), is clinically used with chemotherapy for patients with GBM, yet its impact on the tumor immune microenvironment remains poorly understood. Transcriptomic profiling of matched pre- and post-treatment tumors from patients with recurrent GBM treated with bevacizumab plus the topoisomerase inhibitor irinotecan revealed significant immune reprogramming in responders, with post-treatment tumors displaying features indicative of tertiary lymphoid structure (TLS) formation and enhanced antitumor immunity. In preclinical orthotopic glioma models, combining \u03b1VEGF therapy with intratumoral epidermal growth factor receptor (EGFR)-targeted cytotoxic therapy and \u03b1CD40 immunotherapy normalized the tumor vasculature, promoted lymphatic vessel growth, induced tumor cell killing, increased intratumoral T cells, plasma cells, germinal center B cells, and antigen-presenting and tissue-repair-associated macrophages, while reducing immunosuppression and supporting mature TLS formation with an antitumor immune phenotype. Functionally, the tumor-, immune-, and vascular-targeted combination therapy significantly improved tumor control, extended survival, and induced durable antitumor memory in glioma models. Collectively, these results identify VEGF as a central regulator of the vascular-immune axis during cytotoxic EGFR+\u03b1CD40 therapy in GBM and provide a strong rationale for combining vascular-, tumor-, and immune-targeted approaches to overcome therapeutic resistance and improve outcomes for patients with GBM.<\/p>","DOI":"10.21203\/rs.3.rs-9350019\/v1","type":"posted-content","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:31:03Z","timestamp":1776436263000},"source":"Crossref","is-referenced-by-count":0,"title":["Anti-VEGF vascular remodeling drives germinal center B cell-rich tertiary lymphoid structures during antibody-toxin and anti-CD40 combination therapy in glioblastoma"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7190-8444","authenticated-orcid":false,"given":"Anjali","family":"Barnwal","sequence":"first","affiliation":[{"name":"Duke University Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixuan","family":"Yan","sequence":"additional","affiliation":[{"name":"Duke University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0516-9388","authenticated-orcid":false,"given":"Sarah","family":"Cook","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Urup","sequence":"additional","affiliation":[{"name":"Danish Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Stevenson","sequence":"additional","affiliation":[{"name":"Duke University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"He","sequence":"additional","affiliation":[{"name":"Duke University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Osorio","sequence":"additional","affiliation":[{"name":"Duke University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Parker","sequence":"additional","affiliation":[{"name":"Duke University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwige","family":"Edouard","sequence":"additional","affiliation":[{"name":"Duke University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Bowie","sequence":"additional","affiliation":[{"name":"Duke University Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter","family":"Jackson","sequence":"additional","affiliation":[{"name":"Duke University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6682-4588","authenticated-orcid":false,"given":"Roger","family":"McLendon","sequence":"additional","affiliation":[{"name":"Duke University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3869-8283","authenticated-orcid":false,"given":"Annick","family":"Desjardins","sequence":"additional","affiliation":[{"name":"Duke University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4754-5900","authenticated-orcid":false,"given":"David","family":"Ashley","sequence":"additional","affiliation":[{"name":"Duke University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darell","family":"Bigner","sequence":"additional","affiliation":[{"name":"Duke University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0653-3014","authenticated-orcid":false,"given":"Vidyalakshmi","family":"Chandramohan","sequence":"additional","affiliation":[{"name":"Duke University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9350019\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9350019\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:32:16Z","timestamp":1780414336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9350019\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":0,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-9350019\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,4,17]]},"subtype":"preprint"}}